Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for postoperative pain in breast cancer surgery
NCT00210210Phase 3Completed
- Sponsor
- Institut Bergonié
- Start
- Jan 2004
- Primary completion
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketamine in postoperative pain (2 arms), sponsored by Institut Bergonié. Primary endpoint: Morphine Consumption (First 48 Post-operative Hours) at 48 hours. Started Jan 2004; status: completed.
02
Drugs
ketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT00210210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00210210.